May 2016
The industry will never get to bask in do-gooder glory. But complications from diabetes are down. Programs targeting prediabetes are working. We know what to do, a top doctor declares. Now is the time to organize delivery to do it.
Timothy Kelley
Diagnoses of diabetes go up with expansion. Optimists see a new chance to prevent expensive complications and help with behavioral health issues.
Robert Calandra
Details are yet to come, but officials hope to replicate the impressive clinical and cost saving achievements garnered in a program that has been run out of selected YMCAs.
Frank Diamond
Many new digital health care tools focus on what has too often stumped anti-diabetes efforts in the past: lack of patient engagement.
Thomas Reinke
Up to 70% of people with prediabetes eventually go on to develop type 2 diabetes. But dietary changes and increased physical activity can slow or even prevent progression to full-fledged diabetes.
Jack McCain
David Gregory, MPA
Dennis J. Scotti, PhD, MS, MBA
Daniel Buck, MBA, MPH
George Triadafilopoulos, MD
Departments
Legislation & Regulation: Campaign 2016
Pharma will fight it, but Donald Trump and Bernie Sanders both see liberalization of the rules for drug importation as a way to bring prices down.
Richard Mark Kirkner
Tomorrow’s Medicine
A CDC program shows that diabetes prevention works. Solera hopes to link up health plan enrollees with digital and community-based prevention programs.
Thomas Morrow, MD
Viewpoint
Richard G. Stefanacci, DO
The Formulary Files